Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: The Objective is to Evaluate the Anterior Chamber Angle After BANG Procedure, the Study Will Recruit 12 Patients Who Will Undergo Planned Goniectomy for Uncontrolled POAG, Anterior Segment OCT Scan Will Be Used to Evaluate the Anterior Chamber Postoperatively.
This clinical trial will recruit 12 patients with uncontrolled primary open-angle glaucoma to evaluate the anterior chamber angle after the …
-
FDA approval · 2024-07-26FDA Approved: ACETAZOLAMIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Acetazolamide under ANDA 202693, submitted by Heritage Pharmaceuticals d/b/a Avet Pharmaceutical…
-
FDA approval · 2024-07-25FDA Approved: ISTALOL — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for ISTALOL (timolol maleate) submitted by Bausch & Lomb Incorporated.
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Cord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-Glaucoma [NA]
Clinical trial evaluating cord blood serum for glaucoma and other neurodegenerative ophthalmic diseases has completed.
-
FDA label_change · 2024-07-18FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Supplemental Application (Micro Labs Limited)
The FDA approved a supplemental application from Micro Labs Limited for a preservative-free dorzolamide hydrochloride and timolol maleate pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients [Phase 3]
Phase 3 trial comparing T4032, unpreserved bimatoprost 0.01%, to Lumigan 0.01% in patients with ocular hypertension or glaucoma. The study h…
-
FDA approval · 2024-07-12FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION — Original Application (Gland Pharma Limited)
FDA approved a generic travoprost ophthalmic solution (ANDA) from Gland Pharma Limited, expanding access to a prostaglandin analog for reduc…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Assessment of an Automated Optical Coherence Tomography and Camera : Effectiveness of Vision-700
A completed clinical trial evaluating Vision-700, an automated optical coherence tomography and camera system, across subjects including gla…
-
CLINICAL_TRIALS other · 2024-07-10Clinical Trial Update: Vitreopapillary Interface and Optic Disc Morphology
Clinical trial update on the vitreopapillary interface and optic disc morphology with ongoing recruitment for posterior vitreous detachment,…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial [NA]
A randomized controlled trial protocol investigating acupuncture as an adjuvant therapy for glaucoma, with outcomes focused on intraocular p…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Investigating Multimodally Endothelial Dysfunction in Ocular and Systemic Disease [NA]
A clinical trial investigating multimodal endothelial dysfunction in ocular and systemic disease, including kidney diseases, diastolic heart…
-
FDA approval · 2024-07-03FDA Approved: TIMOLOL HEMIHYDRATE — Original Application (Somerset Therapeutics, LLC)
FDA approved a generic timolol hemihydrate eye drop for lowering intraocular pressure in adults with glaucoma or ocular hypertension.
-
FDA approval · 2024-07-03FDA Approved: TIMOLOL MALEATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for a generic timolol maleate product (ANDA) from Somerset Therapeutics, LLC, for lowering intraocular…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Preoperative Visual Aids on Glaucoma Surgical Patients [NA]
A completed clinical trial update assessing the impact of preoperative visual aids on glaucoma surgical patients.
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care
A completed clinical trial comparing virtual reality visual field devices to standard care in glaucoma, focusing on patient performance.
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Pivotal Trial for a Synthetic Tissue Substitute for Concealment of Artificial Ocular Implants [NA]
The pivotal trial evaluating CorNeat Vision Ltd.'s synthetic tissue substitute for concealing artificial ocular implants has been terminated…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies
The trial reports on culturing trabecular meshwork cells from biopsies of patients with primary open-angle glaucoma; the study has completed…
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Glaucoma Portugal Screening Trial [NA]
A glaucoma screening trial in Portugal is currently enrolling by invitation. The study is sponsored by Centro Hospitalar Universitário Lisbo…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Evaluation of Visual Training System in Patients With Glaucoma [NA]
A clinical trial evaluating a visual training system for glaucoma; the current status is UNKNOWN.
-
FDA approval · 2024-05-28FDA Approved: TIMOLOL GFS — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for TIMOLOL GFS (timolol maleate) submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Bulbicam Validation on Glaucoma- and Cataract Patients
A completed clinical trial evaluating Bulbicam in patients with glaucoma and cataract, sponsored by Meddoc.
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Vivity Outcomes in Patients With Early Stage Glaucoma
A completed clinical trial evaluating Vivity outcomes in patients with early-stage glaucoma; sponsor is Vance Thompson Vision.
-
CLINICAL_TRIALS withdrawal · 2024-05-20Clinical Trial Update: Effect of Negative Pressure on Pattern Electroretinography Readings [NA]
A clinical trial examining the effect of negative pressure on pattern electroretinography readings in glaucoma-related conditions has been w…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: CLAD Deconvolved PERG Responses in Glaucoma Patients [NA]
A recruiting clinical trial sponsored by Jorvec Corp is investigating CLAD deconvolved PERG responses in patients with glaucoma or glaucoma …
-
FDA approval · 2024-05-15FDA Approved: ACETAZOLAMIDE — Supplemental Application (Lifestar Pharma LLC)
FDA has approved a supplemental application for acetazolamide submitted by Lifestar Pharma LLC.